Chandreyee Das, Author at QuartzBio

About Chandreyee Das

This author has not written his bio yet.
But we are proud to say that Chandreyee Das contributed 8 entries already.

Entries by Chandreyee Das

What’s your ICH E6(R3) Readiness Score?

The new ICH E6(R3) GCP guideline, impacting clinical studies starting 23 July 2025, introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including biospecimens, their derivatives, and all associated clinical and assay data generated during trials. To help precision medicine teams ensure they meet these new requirements, we have developed this compliance checklist.

QuartzBio Platform Version 11.0.0: Dashboard Time-Savers, Organizational Sharing, Statistical Analysis

This month, we released version 11.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and performance improvements to our data management layer.

The Dawn of the Frontier Firm: How AI Agents Are Reshaping Work & Precision Medicine

I just read Microsoft’s latest Work Trend Index report, “The Year the Frontier Firm Is Born,” and it resonates deeply with the challenges and opportunities we’re seeing in precision medicine R&D. Read about QuartzBio’s approach and find links to additional resources on deploying precision medicine AI agents.

Webinar: Precision Medicine AI Agents Accelerate Data-to-Insights

Join this webinar to learn how to use QuartzBio’s Precision Medicine AI Agent Platform. You can ask questions, get answers, and gain insights at the speed of decision-making.Domain-specific AI agents, orchestrated by our Precision Medicine Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.

Podcast: Integrating AI into Precision Medicine

Watch the full episode: Tobi Guennel, PhD, SVP of Product Innovation at QuartzBio, joins AI expert Srivatsan Nagaraja to discuss his insights on integrating AI into the precision medicine value chain in an episode of the Life Sciences D’n’A Podcast. Tune in to learn about: Can’t see the video? Accept cookies to watch: Contact us […]

From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI

The promise of precision medicine starts with the sample data value chain. This value chain was the focus of an exciting session at the 2025 SCOPE Summit for Clinical Operations Executives. QuartzBio’s Tobi Guennel, PhD, inspired lively discussion in his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI.”He explored the opportunities for technology to empower the people and processes across the entire sample data value chain.

QuartzBio Platform Version 10.0.0: Flexibility, Efficiency and Accuracy

19 December 2024 — Before we celebrate the new year, let’s celebrate new feature releases, brought to you by the winning collaboration between QuartzBio’s product teams, managed services teams, and, most of all, our clients. This month, we released version 10.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, delivering enhancements to the enterprise Biomarker Data […]

System and Ecosystem Interoperability: How Connectedness Drives Drug Development

Interoperability in Precision Medicine: What does it mean? In modern drug development, connectedness is crucial for success, especially in remote and decentralized teams. This connectedness involves linking people and information to extract shared insights from data and make faster decisions. In practice, this means ensuring interoperability of data, technology, systems, and ecosystems through a scalable, […]